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Abstract: Paramyxoviruses are a family of negative sense RNA viruses whose members
cause serious diseases in humans, such as measles virus, mumps virus and respiratory
syncytial virus; and in animals, such as Newcastle disease virus and rinderpest virus.
Paramyxovirus particles form by assembly of the viral matrix protein, the ribonucleoprotein
complex and the surface glycoproteins at the plasma membrane of infected cells and
subsequent viral budding. Two major glycoproteins expressed on the viral envelope, the
attachment protein and the fusion protein, promote attachment of the virus to host cells
and subsequent virus-cell membrane fusion. Incorporation of the surface glycoproteins into
infectious progeny particles requires coordinated interplay between the three viral structural
components, driven primarily by the matrix protein. In this review, we discuss recent
progress in understanding the contributions of the matrix protein and glycoproteins in
driving paramyxovirus assembly and budding while focusing on the viral protein interactions
underlying this process and the intracellular trafficking pathways for targeting viral
components to assembly sites. Differences in the mechanisms of particle production among
the different family members will be highlighted throughout.
Keywords: paramyxovirus; matrix protein; glycoproteins; virus assembly; viral trafficking;
membrane rafts; virus budding
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1. Introduction
The Paramyxoviridae, a family of enveloped viruses with negative strand, non-segmented RNA
genomes, cause significant disease in humans and animals. Important human pathogens within this family
include measles virus (MeV), mumps virus (MuV) and human respiratory syncytial virus (HRSV),
which is the single largest cause of respiratory tract infections in the pediatric population [1]. In addition,
several paramyxoviruses have recently been identified, including the respiratory pathogen human
metapneumovirus (HMPV) and the deadly zoonotic Hendra (HeV) and Nipah (NiV) viruses [2–4].
Paramyxoviruses also lead to high burdens on agriculture and the global economy by infecting avian
species (Newcastle disease virus (NDV) and avian metapneumovirus (AMPV) [5,6], cattle (rinderpest
virus), as well as pigs (NiV) [3] and horses (HeV) [4]. Paramyxovirus particles are pleomorphic in
shape. For many family members, particles are primarily spherical, and range in size from 150 nm
to 300 nm in diameter; however, a filamentous form predominates for some viruses such as HRSV and
the parainfluenza viruses, and these particles can reach up to 10 μm in length [7–12]. The process by
which paramyxovirus particles are formed and released at the cell membrane involves a series of
highly coordinated and organized events that eventually result in the production of fully infectious
virus particles with the basic structure depicted in Figure 1A. The viral membrane of paramyxoviruses
contains two major glycoproteins required for virus entry into target cells: the attachment protein
(termed HN for hemagglutinin-neuraminidase, H for hemagglutinin, or G for glycoprotein, depending
on the virus) and the fusion (F) protein. These glycoproteins are densely packed on the viral envelope
and form spike layers as seen under cryo-electron microscopy [13,14]. A subset of paramyxoviruses
have an additional surface glycoprotein, the small hydrophobic (SH) protein whose function in the
viral life cycle is less clear since it is dispensable for virus replication in vitro [15–19]. Inside the
viral envelope, the RNA genome is encapsidated by the nucleocapsid proteins (N or NP), forming
the flexible, loosely coiled nucleocapsid structure, termed ribonucleoprotein complex (RNP), to which
the viral RNA-dependent RNA polymerase complexes, made of large polymerase (L) protein and
phosphoprotein (P), are bound. The RNA genomes of paramyxoviruses are 15–19 kb in length and
contain six to ten genes. As is the case for most negative-strand RNA viruses, association of the
paramyxovirus RNP with the viral membrane is mediated by the matrix (M) protein. Matrix proteins
are considered the key organizers of virus particle assembly since they act as bridges between the envelope
glycoproteins and the ribonucleoprotein complexes, can self-assemble into higher order structures, and
bind cellular membranes as well as several cellular factors [20–22].
Figure 1B depicts the general life cycle of paramyxoviruses, which culminates in newly synthesized
virus particles being assembled and released into the extracellular matrix. Infection is initiated upon
binding of the attachment protein to a cell surface receptor, followed by fusion of the viral membrane
to a host cell membrane, a step promoted by the F protein. The viral genome is then released into the
cytoplasm where all the steps of the replication cycle occur. Primary transcription of the negative sense
RNA genome by the viral RNA-dependent RNA polymerase follows the “stop-start” model resulting
in a gradient of mRNA abundance such that genes at the 3'end are transcribed in higher amounts than
genes at the 5'end [1]. Replication of the full-length genome occurs efficiently only after accumulation
of viral proteins and involves production of positive sense anti-genomes which act as templates for
the synthesis of new negative-sense genomic RNA. Progeny genomes can then be used for further
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replication, for secondary transcription, or for incorporation into virus particles. The newly synthesized
RNPs are then transported to selected sites at the plasma membrane where interaction with the viral
integral membrane glycoproteins occurs, followed by membrane scission and release of virus particles.
Incorporation of RNPs and envelope glycoproteins into infectious virus particles is a highly complex
and coordinated process that requires cooperation among the three main structural components of the
virus: the surface glycoproteins, the RNPs and the matrix proteins. While the majority of paramyxoviruses
fit with this overall model, studies on the molecular mechanisms involved in the assembly and budding
of paramyxovirus particles revealed significant differences between members of this family. This review
will focus on novel findings in the understanding of the interplay between surface glycoproteins,
matrix proteins and RNPs during virus particle assembly while highlighting the main differences that
exist among the members of this family.
Figure 1. (A) Schematic of a paramyxovirus particle. The viral envelope, containing two main
surface glycoproteins: fusion protein (purple) and attachment protein (magenta), surrounds
the single stranded RNA genome (gray) which is encapsidated by the nucleocapsid protein
(brown) and bound by phosphoprotein (orange) and the large polymerase protein (yellow).
Underlying the membrane is a layer of matrix proteins (green). (B) Schematic illustration
of the life cycle of paramyxoviruses. Transcription and replication of the viral genome occurs
in the cytoplasm by the action of the viral RNA-dependent RNA polymerase. The newly
synthesized viral components translocate to discrete sites at the infected cell plasma membrane
where assembly and budding of infectious virus particles occur. For details, refer to text.
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2. Interactions among the Viral Proteins are Critical for Glycoprotein Incorporation and
Paramyxovirus Particle Assembly
The three key components in production of infectious paramyxovirus particles, the surface
glycoproteins, the matrix proteins and the RNPs, must coalesce at the plasma membrane to initiate
budding. Interactions among these three components are critical for glycoprotein incorporation and
particle assembly. The matrix protein is generally considered the main driver of paramyxovirus
assembly and can interact with both the glycoproteins and the core RNPs in an orderly manner.
However, paramyxovirus surface glycoproteins are not simply bit players in this process, but instead
can play important roles in directing the process of particle formation.
2.1. Paramyxovirus Surface Glycoproteins
Entry of paramyxoviruses into target cells requires the concerted effort of two glycoproteins on
the viral membrane: the attachment protein and the F protein. The attachment protein is generally
responsible for primary adsorption of the virus to the cell surface by binding proteinaceous or sialic
acid receptors [23–25]. Fusion of the viral envelope to a target cell membrane then occurs, a process
that is driven by very large conformational changes in the F protein [26–28]. Paramyxovirus attachment
proteins are all homotetrameric type II integral membrane proteins [29], but their nomenclature differs
depending on two characteristics: the ability to agglutinate erythrocytes (hemagglutination), and the
presence or absence of neuraminidase activity (cleavage of sialic acid). For the genera Rubulavirus,
Respirovirus and Avulavirus, the attachment protein is termed HN for its ability to cause hemagglutination
(H) and remove sialic acid from carbohydrates (N). The attachment proteins of Morbilliviruses can
agglutinate red blood cells but lack a neuraminidase activity and are thus denoted H. G is used to refer
to the attachment proteins that lack both the ability to bind and to cleave sialic acids, which is the
case for the attachment proteins of Henipaviruses and members of the pneumovirinae subfamily.
Interestingly, the attachment proteins of pneumoviruses differ significantly from attachment proteins
within the paramyxovirinae subfamily, as they are much smaller in size and are not strictly required for
membrane fusion and entry [16,19,30–33]. Recent data strongly suggest that the F protein plays a role
in attachment for members of the pneumovirinae subfamily, and cellular factors which interact with
both RSV F and HMPV F have been identified [34–37].
Evidence from X-ray crystallography on a number of paramyxovirus attachment proteins, including
the HN proteins of NDV, PIV5, and PIV3; the H protein of measles virus and canine distemper
virus (CDV); and the G protein of HeV and NiV, suggests that the attachment proteins exist as a
dimer-of-dimers, with each monomer comprising a short cytoplasmic tail, a single membrane-spanning
domain and a large ectodomain made up of a membrane-proximal stalk region and a C-terminal
globular head domain (Figure 2A) [38–48]. The crystal structures for both the stalk and the head
domains have been obtained, revealing important information about the mechanistic role of the attachment
protein in linking the binding of cell surface receptors to the triggering of F protein-promoted membrane
fusion. The globular head, composed of four six-bladed β-propeller fold monomers, harbors the
sites for receptor binding and enzymatic activity, though the exact location differs according to the virus.
The atomic structures of the stalk domains of PIV5 and NDV showed that this domain forms a four helix
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bundle, and substantial evidence suggests that F interacts with the attachment protein through this stalk
domain [42,49–57]. Interaction of the attachment protein with F is generally required for triggering the
fusion-associated conformational changes needed for membrane fusion.
Figure 2. Conserved domain structures of paramyxovirus fusion protein (A) and attachment
protein (B). Abbreviation: fusion peptide (FP); heptad repeat region (HRA, HRB);
transmembrane domain (TMD); cytoplasmic tail (CT); disulfide bond (S-S).

Paramyxovirus F proteins contain a fusion peptide, two heptad repeat regions, HRA and HRB,
a C-terminal cytoplasmic tail, and a single-pass transmembrane domain which anchors the protein
to plasma membrane (Figure 2B). They are homotrimeric type I proteins that are synthesized in a
fusogenically inactive precursor form, termed F0, and require proteolytic processing into the fusogenically
active, disulfide-linked F1+F2 metastable pre-fusion form [58]. Proteolytic processing of all F proteins
is necessary to expose the hydrophobic fusion peptide needed for membrane insertion, but the protease
responsible for the cleavage differs depending on the virus. Some paramyxovirus F proteins, such as
those of HMPV and Sendai virus, are cleaved by tissue-specific extracellular proteases, so that virus
assembly involves the uncleaved precursor form [2,32,59]. For most paramyxoviruses, the cleaved
metastable pre-fusion F1+F2 heterodimer is the predominant form incorporated into virus particles, so
cleavage must occur prior to virus assembly. For the majority of paramyxoviruses, including mumps,
PIV5, and NDV, processing of F is mediated by the ubiquitous subtilisin-like serine protease furin during
F protein transport through the trans Golgi network, prior to arrival at the plasma membrane [60–62].
Henipavirus fusion proteins require activation by the endosomal/lysosomal protease cathepsin L, an
event that is accomplished after endocytosis of F0 from the cell surface and trafficking to an early
endosomal compartment, followed by re-trafficking to the plasma membrane [63–66]. The HRSV F
protein is unique among paramyxoviruses since it requires two cleavage events for its activation,
one mediated by furin in the TGN prior to assembly, and a second cleavage which is thought to depend
on cathepsin L in an endocytic compartment after endocytosis of the viral particle [67]. The F protein
interacts with its homotypic attachment protein in a temporally and spatially controlled manner, though
the timing of this interaction may vary among different paramyxoviruses. There is evidence that in
some cases, a preassembled F/attachment protein complex is formed prior to packaging into budding
virions, while in other cases, the F and attachment proteins incorporate separately into particles and

Viruses 2014, 6

3024

only interact within the viral envelope upon subsequent receptor binding. Specific interaction between
the fusion and attachment proteins during viral particle assembly will be discussed in more detail in
Section 3.1. Upon receptor binding, the attachment protein transmits a signal to F which triggers a
series of irreversible conformational changes in F leading to the formation of a stable six-helix bundle
formed by the heptad repeat regions and resulting in fusion of the viral envelope with the host cell
membrane [25,68–70].
Some paramyxoviruses including members of the pneumovirinae subfamily, rubulaviruses, and
the unclassified J virus have an additional glycoprotein on the viral membrane, termed SH for small
hydrophobic protein. SH proteins are all type II integral transmembrane proteins, but the size and
proposed function of these proteins differs between viruses. The SH proteins of RSV and HMPV have
been proposed to function as viroporins, or viral protein channels [71–77]. In addition, HMPV SH can
modulate the host immune response and contribute to viral pathogenicity by inhibiting NF-κB [78].
For other paramyxoviruses, SH can inhibit apoptosis by interfering with TNF-α signaling [15,79].
Recent evidence indicates that HMPV SH can also decrease HMPV F-mediated membrane fusion and
inhibit virus uptake in dendritic cells [77,80]. Although studies have shown that SH is dispensable
for virus replication in vitro [17–19,81], deletion in vivo can attenuate viral replication and
pathogenicity [16,30,82–84].
2.2. Matrix Proteins as Coordinators of Paramyxovirus Assembly and Budding
The M protein, the most abundant protein in the virion, plays a fundamental role in paramyxovirus
assembly through its ability to interact with multiple partners. M proteins can self-assemble, bind
directly to cellular membranes, and interact with the RNP complex and the cytoplasmic tails of
glycoproteins, thus allowing the RNP core to associate with a region at the plasma membrane where
the surface glycoproteins are concentrated, which will become the budding site. The importance of
M proteins for paramyxovirus particle production was originally shown in Sendai virus and measles
virus, where mutations in the M gene encoding an unstable M protein was correlated with severe
defects in infectious particle production [85–88]. Our understanding of the role of M protein in the
process of paramyxovirus assembly was enhanced by studies involving virus-like particle formation
(VLPs) and reverse genetics, as recombinant viruses with mutations or deletions in the M gene
revealed the significance of the matrix protein in incorporation of other viral components and in viral
budding. For example, deletion of the measles virus M protein led to an increase in cell-associated
virus and the loss of co-localization of the surface glycoproteins with the RNPs [89]. A recent study by
Mitra et al. showed that infection with an M-null HRSV resulted in impairment of infectious particle
release and alterations in the intracellular localization of the RNP complex as well as in the distribution
of glycoproteins on the plasma membrane, further demonstrating the essential role of M in the assembly
and budding of virus particles [90]. For many paramyxoviruses, including Sendai virus (SeV) [91,92],
MeV [93,94], NiV [95,96], hPIV1 [97], and NDV [98], transient expression of M protein by itself
is sufficient to promote budding of VLPs, indicating that the M protein of these viruses has the ability
to efficiently associate with membranes, induce membrane curvature and promote scission. Although
matrix proteins of different paramyxoviruses display similar functions, they vary greatly in length and
amino acid sequences.
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Recent structural studies on paramyxoviruses involving crystallography and cryo-tomography
revealed important information on how the structure of M and how its organization within virions
allows M to function in assembling viral components and inducing membrane deformation. The
atomic structures of M proteins of three paramyxoviruses, NDV [99], HRSV [100] and HMPV [101]
were recently solved. These M proteins share similar overall structures, including the presence of positive
charges on the surface of the molecule which are observed in other mononegavirales matrix proteins
including Ebola virus VP40 [102] and Borna disease virus (BDV) M protein [103]. Although the
NDV and HMPV M proteins were crystallized as dimers while the HRSV M protein was found in a
monomeric form, structural alignment revealed similarities in the N-terminal domain (NTD) and
C-terminal domain (CTD) of these proteins [99–101]. The monomeric subunits of NDV, RSV and
HMPV M proteins are composed of two beta-sheets containing folded domains that are connected by
an unstructured, flexible linker region. The linker region is thought to play a dynamic role in promoting
structural plasticity of M which is essential for the ability of the protein to interact with multiple
binding partners and with itself. Matrix-like proteins are known for their ability to form higher order
assemblies involving NTD/NTD and CTD/CTD interfaces. For SeV, it has been shown that M can
self-assemble in vitro into helices and sheets [104,105]. Binding of HRSV and HMPV M proteins to
lipids promotes self-assembly and polymerization of M subunits into long flexible helical filaments
with different curvatures [101,106]. It is thought that the dimer subunits of M can associate through
different side-by-side interactions which influence that curvature of the matrix arrays and thus virus
morphogenesis. Paramyxovirus M proteins, similar to matrix proteins of other negative-strand RNA
viruses, also have an intrinsic ability to bind membranes [107–111], and the matrix protein of NDV
was even shown to adsorb onto phospholipid liposomes and self-assemble to induce membrane
deformation [112]. However, the exact nature of the interaction of M with membrane lipids is not
yet clearly understood. The atomic structures of the paramyxovirus M proteins are characterized by
the presence of a positively charged area on the surface of the molecule, most likely involved in
electrostatic interactions with the negatively charged surface of cell membranes. Binding of M to
the lipid bilayer is suggested to be driven by basic residues in the CTD as well as by hydrophobic
interactions [100]. Interestingly, comparison of amino acid sequences of pneumovirus M proteins
revealed high similarity in the CTD and more disparate sequences in the NTD, suggesting further that
the C-terminal interactions of different paramyxovirus M proteins with membranes are of a similar
nature and that the NTD is involved in specific protein interactions of M with other viral and cellular
factors [100]. This would thus explain the ability of various paramyxovirus M proteins to coordinate
different protein-lipid and protein-protein interactions. The matrix protein of HMPV has an additional
unique feature in its NTD not seen in other mononegaviral matrix proteins to date which is the
presence of a Ca2+ binding site [101]. This suggests that binding of Ca2+ to HMPV M may represent a
new mechanism by which M proteins of paramyxoviruses are regulated to organize particle assembly.
Despite the essential role of the M protein in paramyxovirus particle production, the mechanisms by
which M regulates the assembly and budding processes vary among different members of the family.
Unlike SeV, MeV, NDV, NiV and hPIV3, where the M protein is sufficient for VLP formation, other
paramyxoviruses require interactions of M with the surface glycoproteins or with the RNP for particle
formation, indicating that there are significant variations in the function of M and in the strategies that
different family members employ for efficient particle production. Differences in the role of M in the
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assembly of paramyxoviruses were also demonstrated by electron cryo-tomography showing the 3D
structures of virus particles. While the general ultrastructural model of paramyxoviruses depicts M
protein as lining the inner leaflet of the viral envelope, recent cryo-tomography data show that this
structure does not apply to all paramyxoviruses. For RSV, NDV and SeV, M forms a layer under
the viral membrane only in a small percentage of virus particles. In the majority of particles, M was
observed to be dissociated from the membrane and disassembled, potentially to allow the conformational
changes of the F protein from the pre-fusion to the post-fusion form by releasing interactions with
the F cytoplasmic tail [99,113,114]. A recent study revealed that for RSV, the surface area of the virion
membrane which is covered by M varies significantly depending on the morphology of the virus
particle, with the highest coverage (86%) detected in filamentous particles and the lowest (24%)
in spherical viruses [115]. The arrangement of the surface proteins and the matrix proteins in the
3D structures of NDV and RSV suggest an interaction between these two viral components. In MeV,
on the other hand, M protein was not located under the viral membrane but was found to assemble on
the RNP forming a bundled two-layer helical structure inside the virion [116]. These findings suggest
significant mechanistic differences in the way M interacts with the RNPs and envelope proteins to
assemble virus particles.
2.3. Interaction of Ribonucleoprotein Complex with Glycoproteins and M
During replication, the newly synthesized genomic RNA is tightly wrapped with the nucleoprotein
for protection from degradation, forming a helical RNP complex [117]. Encapsidation of RNA by N
does not depend on specific nucleotide sequences, as expression of N in the absence of infection can
result in the formation of nucleocapsid-like structures resulting from N non-specifically binding host-cell
RNAs [92,97,118–120]. Prior to virus budding, newly synthesized RNPs must assemble with the
surface glycoproteins and the M protein at the plasma membrane. While multiple copies of the RNA
genome can be packaged within a single particle [114,115,121,122], incorporation of RNPs into virions
is selective and likely depends on species homology between M and the nucleocapsid protein, genome
length, and to a lesser extent on the polarity of the genome [123–125]. Targeting of RNPs to the plasma
membrane assembly sites is primarily mediated by the M protein. M proteins of several paramyxoviruses,
including SeV, MeV and PIV5, are known to interact with the nucleocapsid protein to mediate
incorporation of the RNPs into virions [123,126,127]. Studies using recombinant viruses also demonstrated
that deletions or mutations of the M gene can block RNP complex transport to the plasma membrane
during infection, further supporting the important role of M protein in RNP inclusion into virus
particles [90,94]. Within the pneumovirinae subfamily, association of M with the RNP can occur through
interaction of M with the transcription elongation factor, M2-1 protein, which is also considered a
component of the RNP complex [113,115,128]. M can also bind RNA directly or can bind to the large
polymerase L protein [129,130]. In addition to interacting with M to facilitate their incorporation into
virions, in some cases the paramyxovirus nucleocapsid proteins play a role in increasing efficiency
of VLP budding [14,119]. Co-imunoprecipitation experiments showed that the fusion protein of NDV
interacts with the NP protein in purified VLPs and not with the M protein, suggesting that interaction
of F with NP may be involved in localization of NP at plasma membrane assembly sites [98]. In other
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cases, such as SeV, interaction of the M protein with a viral glycoprotein is required for concentration
of the RNPs at the plasma membrane and their subsequent assembly into particles [131].
2.4. Active Role of Glycoproteins in Paramyxovirus Particle Formation
While the role of M proteins as organizers of paramyxovirus assembly has been well established,
the important function of membrane proteins in the late phases of paramyxovirus infection has gradually
become clearer. Surface glycoproteins of paramyxoviruses are well characterized for their significance
in membrane fusion and viral entry; however, substantial evidence implicates an active role of these
membrane glycoproteins in the end stages of the virus replication cycle (reviewed in [20,21]).
Paramyxovirus glycoproteins can specify the location for viral budding through interactions with lipids,
associate with the M protein to aid in assembly, and in some cases, interact with RNPs as part of virus
assembly. For assembly of infectious particles, M must target the cytoplasmic RNPs to the budding
site at the plasma membrane where the viral integral membrane glycoproteins are concentrated, thus
paramyxovirus M proteins are suggested to bind membranes at areas enriched with the envelope
proteins. Consistent with this view, the ultrastructure of NDV revealed that the M protein forms a
grid-like array where the glycoproteins were densely packed [99]. In addition, an inner layer of
membrane-bound M was associated with regular spacing of the pre-fusion F protein in RSV virions,
further supporting an interaction between M and F [113]. Studies have demonstrated that membrane
proteins interact with the matrix protein for a number of paramyxoviruses, and this interaction is
needed to organize assembly and for the incorporation of glycoproteins into budding virus particles,
but many differences exist between various members with respect to the contribution of this interaction
to particle formation and the individual roles of the attachment and fusion proteins. For SeV, M can
interact with both F and HN [132–134] but only the fusion protein is important for virus production
and its function is as critical as that of M since alterations in F can attenuate virus production up to
70% [134–136]. Expression of glycoproteins was also shown to be important for budding of VLPs. For
PIV5, F and HN have redundant functions during VLP formation, while mumps F protein, but not
HN, enhance particle release [14,119,137,138]. Loo et al. have recently shown that while HMPV M
interacts with both F and G proteins, expression of HMPV G facilitates formation of VLPs [10].
Specific interactions between M and HN of NDV have also been reported; however, this interaction
does not have an effect on efficiency of VLP release [98]. Similar results were seen for MeV,
NiV and RSV, indicating that glycoproteins can enhance budding efficiency for only a subset of
paramyxoviruses [93,95,96,139].
In addition to their contribution to the budding process, paramyxovirus glycoproteins are also
implicated in assembly of other viral components. The fusion protein of RSV was shown to be responsible
for incorporation of G and SH proteins into budded virions and for their co-localization with N at
plasma membrane assembly sites; however, F deletion had no effect on M assembly into virions [139].
A key function for the fusion protein in SeV assembly was shown, as mutations in F altered cellular
localization of both HN and M, although interaction of F with M was not affected [131]. These
findings indicate that the paramyxovirus glycoproteins can play significant roles in the assembly and
budding processes, but different paramyxoviruses utilize their glycoproteins differently.
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2.5. Role of the Cytoplasmic Tails of Glycoproteins in Particle Production
Paramyxovirus surface glycoproteins contain short cytoplasmic tails which extend on the inner
side of the plasma membrane. The length and amino acid sequences of these domains in the fusion and
attachment proteins vary significantly among different paramyxovirus members (Figure 3). Several
studies have demonstrated that the role of paramyxovirus glycoproteins in particle formation depends
on their cytoplasmic tails, as these regions are required for glycoprotein incorporation into packaged
particles and for glycoprotein interactions with M. Biochemical and co-localization studies revealed
that M can interact with the cytoplasmic tail of the homotypic attachment proteins for RSV, HMPV,
NDV and measles [10,98,140,141]. These finding are surprising for the pneumoviruses RSV and
HMPV since G is dispensable for viral replication in vitro [30,31]. This suggests that while interaction
of M with G is dispensable for virus production in these cases, the presence of G may contribute to
optimal virus production manifested by an increase in HMPV VLP formation [10] and a role for G
in SH incorporation into RSV particles [139]. The importance of the glycoprotein cytoplasmic tails for
paramyxovirus particle production was also demonstrated for PIV5, as deletion of these domains
in either F or HN prevented assembly of M and the glycoproteins at the cell surface, and removal
of the cytoplasmic tail of the HN protein significantly decreased virion egress [119,138]. For other
paramyxoviruses, the cytoplasmic tail of F protein plays an important role in late stages of viral infection.
The cytoplasmic tails of MuV and hPIV1 F proteins are involved in particle assembly [14,142]. For
RSV, formation of viral filaments depends on the cytoplasmic tail of the fusion protein [139,143].
In addition, alterations in the cytoplasmic tail of SeV F protein significantly affected virus replication
and the clustering of HN, M and NP at assembly sites, indicating a role for the cytoplasmic tail of the
fusion protein in coordinating the assembly of the different viral components [131,142]. For measles
virus, truncations in the cytoplasmic tails of F and H do not alter assembly of viral components at the
cell membrane but do affect the incorporation of F, M and H into released particles [144]. Deletion of
the cytoplasmic tail of measles virus F protein is associated with increased cell-cell fusion, similar to
what is seen for the MeV strain obtained from subacute sclerosing panencephalitis (SSPE) patients.
It has been suggested that interaction of M with the cytoplasmic tails of F locks F in the pre-fusion
conformation during the process of assembly; thus removal of the cytoplasmic tail, and loss of the M
interaction domain, facilitates fusion [89,113,145]. The importance of the glycoprotein cytoplasmic
tails for particle assembly appears to be a common feature of many RNA viruses, as truncations in the
cytoplasmic tails of the glycoproteins hemagglutinin [146] (HA) and neuraminidase (NA) of influenza
A virus or of the rhabdovirus G result in severe defects in particle formation [147,148]. Figure 3 shows
the differences in the length and amino acid sequences of the cytoplasmic tails of different paramyxovirus
glycoproteins. It is believed that the function of the cytoplasmic tails of glycoproteins in paramyxovirus
particle formation depends on specific amino acid sequences or signals rather than simply a defined
length. The sequences that have been shown to affect the role of the fusion and attachment proteins in
particle production are highlighted [91,131,140,143,144,149–154]. For SeV, it was shown that while
random truncations and mutations in the cytoplasmic tail of F affected virus production to varying
extents, the strongest effect on accumulation of virus components at the cell surface and virus egress
was detected in particles carrying F proteins with mutations in a TYTLE motif [91,131]. A four amino
acid sequence with a critical phenylalanine residue in the cytoplasmic tail of HRSV F protein was
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shown to coordinate virus filament assembly and budding [143,146]. Specific sequences crucial for the
insertion of attachment proteins into virions have also been identified for NDV and SeV HN proteins
(Figure 3B) [149,153]. These findings suggest that even though the cytoplasmic tails of paramyxovirus
glycoproteins are needed for their inclusion into infectious viruses, the roles of these domains in
different viruses may vary.
Figure 3. Amino acid sequences of the cytoplasmic tails of the fusion protein (A) and
attachment protein (B) of different paramyxoviruses. Amino acid residues highlighted
contribute to paramyxovirus particle production. Sequences of cytoplasmic tails were
obtained from UniProt.

3. Intracellular Trafficking of Viral Components
During paramyxovirus replication, the glycoproteins, matrix proteins and RNPs are synthesized
at distinct sites in the cytoplasm and must be transported to the plasma membrane for coordinated
assembly. The different viral components reach the plasma membrane by different mechanisms
and interact with each other in an orderly manner either during trafficking or at the cell surface prior
to packaging into virions. Paramyxovirus proteins are carried to the cellular plasma membranes by
utilizing various cellular machineries including endocytic and exocytic pathways, in addition to vesicular
trafficking and the cytoskeleton.
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3.1. Trafficking of Viral Glycoproteins
Paramyxovirus glycoproteins are synthesized in the endoplasmic reticulum (ER) and traffic through
the secretory pathway, and in some cases through endocytic pathways, to the plasma membrane.
Proper trafficking is needed for incorporation into budding virions or induction of cell-cell fusion for
direct cell-to-cell transmission of virus particles. For some paramyxoviruses, data indicate that the
fusion and attachment proteins can interact following their synthesis in the ER, and thus are transported
to the cell surface as a metastable protein complex. This has been suggested to occur for NDV, MeV
and human parainfluenza viruses 2 and 3 [155–157]. Alternatively, the F protein and the attachment
protein can traffic separately and only associate after reaching the plasma membrane, which is the case
for HeV and NiV [158,159]. For PIV5, F and HN also associate at the cell surface but formation of the
F-HN complex requires receptor binding [68]. During their synthesis in the ER, glycoproteins must
undergo proper folding and oligomerization prior to trafficking to the cell surface. Mutational analyses
showed that mutations which interfere with proper folding or assembly of the final oligomeric
structure of paramyxovirus glycoproteins generally result in their retention in the ER and prevent their
transport through the exocytic pathway to the cell surface [160–163]. The contribution of the ectodomain
in proper folding and stability of the trimeric fusion protein or the tetrameric attachment protein is well
established, but substantial evidence also indicates an important role of the transmembrane domains
and cytoplasmic tails in the oligomerization process and folding of the ectodomain [29,162,164,165].
Mutation of a TYTLE motif in the cytoplasmic tail of SeV F protein prevented its transport to the PM,
and the protein was instead retained in the ER. This failure to traffic was hypothesized to be due to
the failure of the F mutant to trimerize [131]. Similar findings were reported for the PIV5 HN protein,
as deletion of the cytoplasmic tail prevented its assembly to an oligomer and transport to the cell
surface [163]. In addition to their role in protein oligomerization, the cytoplasmic tails are thought to
facilitate proper trafficking of glycoproteins to the cell surface by binding cellular factors that direct
protein targeting to the plasma membrane and by harboring residues that facilitate interaction with
negatively charged lipids at the plasma membrane. N-glycosylation can also be essential for the proper
folding, stability, intracellular transport, and surface expression of the paramyxovirus glycoproteins.
Removal of N-glycans from the glycoproteins of NDV, CDV, PIV5, SeV, HeV and NiV had a significant
effect on their exocytic transport and surface expression [166–172]. However, removal of all
three N-glycans did not affect transport of the RSV F protein to the cell surface indicating that the
degree to which N-glycosylation influences proper folding and transport varies among paramyxovirus
glycoproteins [173,174].
Trafficking of viral glycoproteins has been demonstrated to involve tyrosine-based and di-leucine
motifs which are involved in protein trafficking in both secretory and endocytic pathways. Several
paramyxovirus glycoproteins have endocytic signals and can undergo internalization following
trafficking to the plasma membrane [65,175–178]. For instance, the cytoplasmic tails of NiV and HeV
F proteins contain a tyrosine-based motif (YXXΦ), where X is any amino acid and Φ is a residue
with a bulky hydrophobic side chain that is required for internalization of the protein from the cell
surface [65,178]. PIV5 HN is internalized from the plasma membrane by clathrin-coated pits but its
internalization depends on a single glutamic acid residue at the boundary between the transmembrane
domain and the ectodomain [176,179]. Henipavirus fusion proteins are the only paramyxovirus
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glycoproteins that have an absolute dependence on endocytosis for proteolytic activation by
cathepsin L [63,65,66,180]. With the exception of Henipaviruses, the relevance of endocytic signals in
viral envelope glycoproteins is not yet well established. It has been proposed that down-regulation of
attachment and fusion protein expression on the cell membrane may be a post-translational regulatory
mechanism that plays an important role in viral pathogenicity through minimizing recognition of
antigens on the infected cells by the immune system. Endocytic signals in viral glycoproteins can
also affect efficiency of glycoprotein incorporation into virions and virus assembly. Mutation of
the internalization signal in PIV5 HN has been shown to affect the incorporation of both F and HN
into budded virions [181]. Interaction of the surface glycoproteins with the core matrix proteins
may regulate expression of the paramyxovirus glycoproteins on the cell surface and decrease
internalization of the glycoproteins, thus favoring their incorporation into assembled virus particles
over endocytosis [89,145,182,183].
Paramyxoviruses can infect cells that are polarized in nature, such as neurons, epithelial cells,
endothelial cells and lymphocytes. The plasma membrane in polarized cells is divided into two discrete
domains, the apical domain and the basolateral domain, and this polarity is maintained by sorting of
proteins and lipids in the TGN or secretory pathways and recycling endosomes [184]. Several studies
conducted on paramyxoviruses in polarized systems have revealed important information about the
sorting of the surface glycoproteins between apical and basolateral sides. Motifs for internalization and
polarized targeting generally share common elements that can interact with specific adaptor complexes,
such as the cytoplasmic adaptor proteins, and thus selectively recruit protein cargo into endosomes,
lysosomes or target them to basolateral cell membrane [185]. Recognition of two separate signals
for endocytosis and basolateral sorting may be regulated by interaction with other viral components.
NiV glycoproteins expressed from plasmid DNA are located primarily at the basolateral surface of
epithelial cells, and this localization depends on tyrosine signals (YXXΦ) in the cytoplasmic tail of
Nipah F and on a dityrosine signal in the Nipah G protein [150]. The F and H proteins of measles virus
also have tyrosine-dependent sorting signals in the cytoplasmic domains that mediate their targeting to
the basolateral site of polarized epithelial cells and facilitate cell-cell fusion between epithelial cells.
Transport of measles F and H is not interdependent but each protein traffics alone, as mutation of
tyrosines in one protein does not affect localization of the other [186,187]. Additional motifs in cytoplasmic
domains that direct basolateral targeting have been identified in non-viral systems, and include the
tetrapeptide NPXY motif, dileucine motifs and single leucine residues [188,189]. Fitting with this,
a dileucine motif in the cytoplasmic tail of the NDV F protein was shown to be important for the
basolateral sorting of the protein [152]. A role for the TMD in intracellular transport of integral
membrane proteins is being increasingly recognized. For example, amino acid residues S490 and Y498
in the TMD of Hendra virus F protein were found to be critical for endocytic trafficking and recycling
of the protein to the cell surface [154,164,190]. The hypothesis that the localization of surface
glycoproteins determined the site of virus budding was dominant for a considerable time, but substantial
evidence indicates that this is not accurate in many cases. Directional budding is determined by the
matrix protein for several enveloped viruses, including influenza, Marburg virus and VSV [191–194].
The paramyxovirus M protein is also considered the main determinant of virus budding sites. Crucial
evidence for the central role of M in determination of budding sites was obtained from studies on MeV
and NiV, where experiments showed that while the glycoproteins are intrinsically targeted to the basal
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side of polarized membranes, budding of virus particles occurs at the apical side where the M protein
is concentrated, and expression of M during infection partially redirects the glycoproteins to apical
surface [150,186,187,195–197]. Basolateral sorting of the fusion and attachment proteins can contribute
to the pathogenesis of the virus by mediating transmission of viruses to underlying tissues by cell-cell
fusion. For RSV, both the M protein and the glycoproteins are targeted to the apical side of polarized
epithelial cells, but the glycoproteins are dispensable for apical sorting of M and for virus budding
at the apical side, further confirming the essential role of M in directionality of budding [198].
Apical targeting of membrane proteins depends on signals either in extracellular domains or in the
TMD. For example, the TMDs of influenza HA or NA are necessary for polarized sorting of the
two proteins [184,199,200]. The TMD of RSV fusion protein also plays a role in the polarized sorting
of the protein to the apical side [201]. Apical targeting can also be established by alternative mechanisms.
Association of proteins with lipid rafts (cholesterol and sphingolipid rich domains) can facilitate
transport of protein cargo to apical membranes, and raft association has been shown for several
paramyxovirus glycoproteins as well as for several paramyxovirus M proteins [202]. This will be
discussed in more detail in the following section. Signals for basolateral sorting are usually dominant
over apical signals, so retargeting of paramyxovirus glycoproteins from the basal to the apical side
during infection requires masking of basolateral targeting signals [203–205]. Transcytosis from
the basolateral to the apical side, which requires endocytosis from the specific domain, delivery to
endosomes, and trafficking to the apical surface can also occur, and involves apical recycling endosomes
(ARE). Sorting of the M protein and glycoproteins of measles to different membrane domains during
infection indicates that trafficking of M occurs independently of the surface proteins. This is consistent
with the finding that the matrix protein of measles is not co-transported with glycoproteins [109].
However, for some paramyxoviruses such as SeV [206], M associates with the glycoproteins before
reaching the plasma membrane. For RSV, M and F were found to localize in inclusion bodies (IBs)
in the cytoplasm for the formation of assembly complexes prior to trafficking to the surface of nonpolarized
cells. Deletion of the cytoplasmic tail of F altered the cellular localization of both proteins, with both
M and F found concentrated in inclusion bodies and not in filaments on the cell surface. Although
a direct interaction between RSV M and F has not been shown, F and M targeting to the plasma
membrane requires the cytoplasmic domain of F [146]. Interestingly, RSV F and M were shown to
traffic to the apical side independent of one another suggesting that polarized sorting of viral proteins
can vary significantly from non-polarized trafficking.
3.2. Intracellular Transport of Matrix Proteins and Ribonucleoproteins
Though originally synthesized in the cytoplasm, the matrix protein and the RNPs must subsequently
translocate to viral budding sites at the plasma membrane; however, very little is currently known
on the mechanisms underlying transport of these critical viral structural components. In the classical
model for paramyxovirus assembly, the matrix protein is thought to interact with the RNP at the cell
membrane to mediate its insertion into budding sites for the production of infectious virus particles.
Substantial data, however, support an alternative model in which the matrix protein associates with the
RNP complex in the cytoplasm prior to translocation to the plasma membrane. Data on both MeV and
SeV suggest that the M protein binds to the RNP in the cytoplasm, and the two components are then
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co-transported to the plasma membrane [94,108]. Further support for an interaction of M with the RNP
in the absence of membrane interactions was provided by the 3D structure of MeV particles, which
showed that measles M protein did not form a layer underneath the viral envelope, but instead associated
with the RNPs to form a helical matrix-covered nucleocapsid structure inside the virion [116].
Data from live cell imaging revealed an important role of the host cytoskeleton in the trafficking
of paramyxovirus RNP complexes. Filamentous RNPs of RSV show myosin-motor driven directional
movement on the actin cytoskeleton [207]. In the case of SeV and MeV, RNPs are transported along
microtubules using Rab11A containing vesicles, key regulators of trafficking within the recycling
endosomal pathways and Golgi to the plasma membrane [208,209]. Rab11 endosomes are also part of
the apical recycling endosome (ARE) pathway which controls apical transport of proteins in polarized
cells, suggesting that this pathway may be particularly important in polarized cells. However, a
requirement for Rab11A in assembly of SeV is observed in both polarized and non-polarized cells. In
contrast, Rab11A dependent transport of measles RNPs is only critical for virus production in polarized
epithelial cells and is not a general requirement for measles RNP trafficking. The Rab11-mediated
recycling pathway is also important for budding of RSV particles from the apical surface [210]. In the
course of RSV infection, the matrix protein localizes in cytoplasmic bodies containing the RNP
complex proteins N, P, L, and M2-1, which are thought to be assembly bodies. Deletion of the matrix
gene prevents the translocation of the viral RNP from the cytoplasmic inclusions to the cell surface
suggesting that for RSV, trafficking of the RNPs depends on trafficking of M [90,211]. These findings
indicate that large differences exist in the trafficking mechanisms of paramyxovirus RNPs. It is yet to
be determined whether the Rab11 mediated pathway is utilized by other paramyxoviruses to transport
the RNPs prior to assembly and if M is associated with the viral RNPs in the Rab11 containing
endosomes to facilitate its trafficking. A recent study demonstrated that the incorporation of HIV1-Env
protein into budding particles is dependent on the interaction of the Rab11-interacting proteins FIP1C/RCP
and Rab14 with the cytoplasmic tail of the protein [212]. This raises the question of whether sorting of
paramyxovirus glycoproteins to the plasma membrane can be mediated by components of the Rab11
pathway and this requires further investigation.
Although the entire replication cycle of paramyxoviruses occurs in the cytoplasm, the matrix
proteins of HRSV, SeV, NDV and NiV have been shown to traffic through the nucleus early during
virus infection. In the case of RSV, localization of M in the nucleus occurs through interaction of
a nuclear localization signal (NLS) with the nuclear import receptor, importin β1, and its exit to the
cytoplasm at later stages of infection is mediated by a nuclear export signal (NES) that directs
Crm-1dependent nuclear export [213]. Nuclear-cytoplasmic trafficking of NiV M was also dependent
on a NLS and a leucine-rich NES [214]. In contrast to both RSV and NiV, the matrix protein of NDV
is present in the nucleus throughout infection, and recent studies indicate that NDV M localizes in the
nucleolus primarily due to interaction with the nucleolar phosphoprotein B23 [215–220]. In all cases,
trafficking of M to the nucleus and its localization there was necessary for later virus budding and
efficient virus production. Although more studies are needed to clarify the biological function of M
protein nuclear localization, it is proposed that M transits to the nucleus at early stages of infection
to allow optimal transcription and translation of viral components, since the M protein of several
paramyxoviruses has been shown to bind RNA directly and inhibit viral transcription [126,130].
Transition of M through the nucleus may also affect host transcription to enhance virus replication
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(similar to the matrix protein of vesicular stomatitis virus) [221,222]. The M protein of RSV has been
shown to induce cell cycle arrest in lung epithelial cells by regulating cellular p53 expression levels,
thus enhancing virus replication [223].
4. Localization of Glycoproteins at Membrane Assembly Sites: A Role of Raft Microdomains
Paramyxoviruses have a host-derived, lipid bilayer envelope containing the membrane spanning
envelope glycoproteins. The assembly of viral membranes is a sophisticated and specific process that
involves coalescence of viral components at discrete sites on cellular membranes and exclusion of
the majority of host cell membrane proteins. Recent data support the idea that viral glycoproteins of
enveloped RNA viruses are not randomly distributed on the cell surface but instead are clustered within
lipid raft membrane microdomains to form the nucleation points for budding [224]. Lipid rafts, which
are rich in cholesterol and sphingolipids, are characterized by a rigid, ordered structure with limited
flexibility and can thus act as platforms for virus assembly (reviewed in [21,225–228]). Lipid rafts can
also be referred to as detergent resistant membranes (DRM) since they are resistant to solubilization
by cold non-ionic detergents such as Triton-X100. The important role of lipid rafts in assembly
and budding of enveloped RNA viruses have been described for HIV-1, influenza virus, Ebola virus
and others [228–231]. Several studies have reported that different paramyxovirus glycoproteins are
selectively targeted to raft microdomains in cellular membranes. For MeV, only F, but not H, has
the intrinsic ability to be incorporated into membrane rafts, and it is thought that two palmitoylated
cysteines in the TMD of F facilitate its interaction with lipid rafts; however, during infection, H is
pulled into raft domains upon association of the H-F complex with membrane rafts [232–234]. On the
other hand, both SeV glycoproteins, F and HN, can associate with rafts when expressed individually or
in combination [235]. During NDV infection, F and HN interact with rafts to facilitate the incorporation
of F-HN complexes into virions [236]. The fusion protein of RSV can also be sorted to lipid rafts in a
process directed by its cytoplasmic tail [237]. In addition to the glycoproteins, other viral components
can be associated with raft domains in membranes. For example, the nucleoproteins of SeV, MeV and
NDV have been found to associate with DRMs [233,236,238]. Matrix proteins can also bind raft
membranes, in some cases regardless of the presence of other viral proteins, as was seen with the M
protein of MeV [93] , and in other instances, like SeV M for example [132], depending on interaction
of M with surface glycoproteins. It has been recently proposed that accumulation of viral components
at cell membranes leads to coalescence of multiple membrane microdomains where viruses create
their own assembly platforms [224,239]. In the case of influenza virus, these clusters of membrane
microdomains are termed viral “budozones”. They are larger in size than regular cellular raft membranes
and their formation is dependent on the M1 matrix protein [225,229,240,241]. It would be of interest to
explore whether such domains can be formed during paramyxovirus assembly and whether their
formation depends on clustering of envelope glycoproteins or on oligomerization of the matrix proteins
underlying the plasma membrane and driving the multimerization of the membrane glycoproteins.
In addition to acting as sites of assembly, raft domains also contribute to the infectivity of the released
viral particles. Disruption of raft microdomains by altering cholesterol levels leads to a decrease in
the formation of infectious particles of NDV and RSV [236,242]. For MeV and SeV, rafts are needed
as platforms for assembly but do not constitute precursors for budding [232,243]. Thus, although
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targeting of viral components to raft membranes seems common among paramyxoviruses, the
functional significance of these microdomains in the viral life cycle varies among the family members.
5. Role of Envelope Glycoproteins in Paramyxovirus Budding
Budding of enveloped viruses is a complex process that requires induction of membrane curvature
followed by membrane scission and release of virus particles. Induction of membrane curvature and
the final membrane fission event requires manipulation of the lipid-lipid interactions within cellular
membranes, and is driven by interactions of viral proteins with membrane lipids in addition to viral-viral
and viral-host protein interactions [244]. The mechanisms underlying budding of paramyxoviruses are
still largely unknown, but it is evident that various paramyxoviruses exit infected cells using different
mechanisms (reviewed in [20,21]). Budding of paramyxovirus particles is driven primarily by the
matrix protein. The M protein binds membranes and homo-oligomerizes underneath the plasma membrane
to drive membrane deformation and promote the needed curvature. As previously mentioned, the M
protein of a number of paramyxoviruses can induce formation of VLPs when expressed by itself [91].
In this case, self-association of M under the membrane may be sufficient to drive membrane
deformation and outward budding of VLPs. It is equally possible that host proteins are recruited by M
to the plasma membrane and thus the host machinery drives the membrane deformation and outward
budding. One of the primary mechanisms involved in the release of nascent virus particles of many
enveloped viruses, such as HIV-1, Ebola virus, and VSV requires a short stretch of amino acids in
the matrix protein with a late budding function known as the “L” domain. These L domains, which
vary among different viruses (P[T/S]AP, PPxY, YxxL), function by recruiting and interacting with
cellular proteins of the endosomal sorting complex required for transport (ESCRT), which are part of
the vacuolar protein sorting (VPS) pathway and are involved in promoting membrane fission steps that
lead to the release of virus particles [245]. The paramyxoviruses PIV5 [119], NDV [220] and mumps
virus [14] rely on the host ESCRT machinery during virus exit, as release of particles was inhibited by
expression of a dominant negative VPS4A. Budding of PIV5, NDV and mumps virus is dependent
on a FPIV-like motif in the M protein [14,220,246], which does not resemble canonical L-domain
sequences, suggesting that these paramyxoviruses may utilize different components of the host ESCRT
that can recognize and bind to a different amino acid sequence. There is increasing evidence that a
growing number of viruses, including influenza virus and VSV, can bud from host cells independent
of ESCRT machinery (reviewed in [244,247]). Budding of RSV [210], NiV [248], MeV [249],
AMPV [250] and HMPV [251] has also been demonstrated to occur in an ESCRT-independent
manner. The mechanisms used by ESCRT-independent viruses to bud from infected cells are still
unknown for many of these viruses. Interestingly, budding and virus release of HRSV is dependent
on Rab11-FIP2, and the Rab11 pathway was also shown to play a role in influenza virus production,
suggesting that viruses may utilize the Rab11 endosomal pathway in a previously uncharacterized
manner to achieve their exit from host cells [210,252].
Although M proteins are considered the driving force for budding of paramyxoviruses, increasing
evidence demonstrates that the glycoproteins can also play a role. Several paramyxovirus glycoproteins
can induce VLP formation by themselves or must be present with the M protein for efficient VLP
formation, indicating that surface glycoproteins in these cases are needed either to recruit M to
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assembly sites or to initiate budding. A major role of glycoproteins in paramyxovirus budding is
well characterized for the SeV fusion protein. Sendai F induces VLP release when expressed alone in
cells, and silencing of the F gene reduces virus production by 70% [134]. The ability of F to bud from
the plasma membrane depends on a TYTLE motif in the cytoplasmic tail of the protein [131,253].
This suggests that the TYTLE motif may be needed to bind a cellular factor that facilitates budding.
Sendai F also interacts with M in the ER and is responsible for carrying M to the plasma membrane.
Interestingly, both proteins were found to contain amino acid sequences that resemble actin binding
domains [91]. The host cytoskeleton has been shown to play an important role in the life cycle of
several paramyxoviruses, and it is thought that cytoskeletal components are involved in paramyxovirus
budding. Large amounts of actin were found associated with SeV particles and, interestingly, mutations
of the actin binding domain in F resulted in a significant reduction in SeV VLP production, indicating
that binding of SeV F protein to actin is important for budding of the virus. The requirement of the
cytoplasmic tail domains of glycoproteins for budding of several paramyxoviruses may indicate that
these domains are involved in binding cellular factors that usually are involved in exocytic pathways.
Another significant role of paramyxovirus glycoproteins in paramyxovirus particle production is
manifested in RSV production. Short filament-like structures containing F and G were seen in cells
infected with M-null virus suggesting that RSV glycoproteins are capable of deforming the cell membrane
and initiating bud formation [90]. Clustering of glycoproteins in lipid raft microdomains may create a
pulling force on the plasma membrane and thus induce an initial membrane deformation that is further
elongated by oligomerization of the matrix protein [113]. These observations suggest that the glycoproteins
of paramyxoviruses can actively contribute to the budding process leading to virus egress from
infected cells.
6. Concluding Remarks
Substantial progress has been made in understanding the mechanisms of paramyxovirus particle
production. Paramyxoviruses form at selected sites at the plasma membrane of host cells as a result of
coordinated interactions between viral components and between viral and cellular factors. The role
of the matrix protein as the principal organizer of the assembly process has been well established, and
recent structural data obtained from several paramyxovirus matrix proteins revealed important
information on the molecular basis of the ability of M to drive particle formation. M can associate
with the plasma membrane, self-oligomerize to form a lattice, and interact with glycoproteins, the RNP
complex and several host factors mainly through its N-terminal domain. The viral protein-protein
interactions involved in particle assembly have been demonstrated for a variety of paramyxoviruses.
While there are differences between members of the family in terms of specific host cell protein
interactions or points of viral protein-protein interactions, the general concepts of coordinated assembly
are consistent. However, the mechanisms by which different viral components reach the plasma
membrane and coordinate their localization at assembly sites still require further investigation. It is
evident from the studies summarized in this review that fundamental differences exist among the
different family members in the mechanisms that underlie coordinated targeting to the assembly
site, and three different models for paramyxovirus assembly can at present be deduced (Figure 4).
What factors determine which mechanism is employed by specific paramyxoviruses for completion of
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their life cycle is currently unknown. It is possible, however, that some family members can employ
more than one assembly mechanism either simultaneously or at different times during infection, depending
on cellular factors or in vivo conditions.
Figure 4. Potential models of paramyxovirus assembly: fusion protein shown in purple,
attachment protein in magenta, matrix protein in green and the RNP complex in brown.

In the first model, the fusion and attachment proteins interact following their synthesis in the
ER and are co-transported to the plasma membrane as a complex. The matrix protein associates with
the RNP in the cytoplasm and carries it to the plasma membrane where it assembles with surface
glycoproteins. This model can be deduced mainly from studies done on MeV. Alternatively, the fusion
and attachment proteins can traffic separately to the cell surface. In some cases, like SeV (model 2),
the fusion protein can bind the matrix protein in the ER, and the two are transported as a complex to
the plasma membrane where they create a nucleation site for assembly. Incorporation of the attachment
protein likely occurs though interactions with M or with F. The RNP can traffic by itself to the assembly
site and is packaged within particles upon binding to M or one of the glycoproteins. Studies of
RSV suggest a third model of paramyxovirus assembly, where the formation of an assembly complex
containing F, M and the RNP core occurs in inclusion bodies in the cytoplasm, with a role of the
cytoplasmic tail of F in targeting M-RNP to assembly sites. While these models, and potentially others
to be generated after future research, provide insight into glycoprotein incorporation and paramyxovirus
assembly, several critical questions remain to be answered to obtain a complete understanding of
paramyxovirus particle formation.
One of the key unanswered questions is how are assembly sites initiated? Is the clustering of
surface glycoproteins in membrane raft domains sufficient to create an outward bud in the plasma
membrane to which other viral components are recruited, or is the interaction of M with the cytoplasmic
tail of glycoproteins and its self-oligomerization the main driver for the formation of assembly
nucleation sites? The requirements for the formation of budding precursor sites may vary among
different paramyxoviruses. For RSV, the fusion protein seems to be the significant contributor for the
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formation of short viral filaments without the need for M or the host cytoskeleton. On the other hand,
the actin cytoskeleton and the interaction between M and the cytoplasmic tail of F appear to drive
SeV particle formation at the plasma membrane. Another significant area of study is to determine the
cellular pathways that are utilized by the matrix proteins and the RNP core that allows their delivery
to assembly sites and subsequent packaging of the RNA genome into virions. Important questions
also remain regarding how membrane budding and the final scission process are established for
paramyxoviruses, particularly for those viruses that do not utilize the well-characterized ESCRT
proteins. What are the cellular factors that play a role in budding of paramyxoviruses, and how are
they recruited by viral proteins? Thus, further studies are still required to clarify multiple aspects of
paramyxovirus particle production and to uncover the differences that exist in the molecular mechanisms
utilized by different paramyxoviruses to form new infectious particles. Future discoveries in this field
may contribute to the development of antivirals against paramyxovirus infections.
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